Taken together, the above results pointed that AP-1 transcriptional complex is essential for cardiomyocyte hypertrophy induced in vitro by Ang II and TGF-β1, but also may be a target for the stem cell-derived EV based therapy of cardiac hypertrophy. The gene discussed is FOS; the disease is cardiac hypertrophy.